miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease that typically leads to respiratory failure and death within 3–5 years of diagnosis. Sub-pleural pulmonary fibrosis is a pathological hallmark of IPF. Bleomycin treatment of mice is a an established pulmonary fibrosis model. W...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Ther
Glavni autori: Zhang, Qian, Ye, Hong, Xiang, Fei, Song, Lin-Jie, Zhou, Li-Ling, Cai, Peng-Cheng, Zhang, Jian-Chu, Yu, Fan, Shi, Huan-Zhong, Su, Yunchao, Xin, Jian-Bao, Ma, Wan-Li
Format: Artigo
Jezik:Inglês
Izdano: American Society of Gene & Cell Therapy 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363213/
https://ncbi.nlm.nih.gov/pubmed/28131417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.12.017
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items